Becnel, M. R., Nastoupil, L. J., Samaniego, F., Davis, R. E., You, M. J., Green, M., . . . Fowler, N. H. (2019). Lenalidomide plus rituximab (R(2)) in previously untreated marginal zone lymphoma: Subgroup analysis and long‐term follow‐up of an open‐label phase 2 trial. Br J Haematol.
Citação norma ChicagoBecnel, Melody R., et al. "Lenalidomide Plus Rituximab (R(2)) in Previously Untreated Marginal Zone Lymphoma: Subgroup Analysis and Long‐term Follow‐up of an Open‐label Phase 2 Trial." Br J Haematol 2019.
Citação norma MLABecnel, Melody R., et al. "Lenalidomide Plus Rituximab (R(2)) in Previously Untreated Marginal Zone Lymphoma: Subgroup Analysis and Long‐term Follow‐up of an Open‐label Phase 2 Trial." Br J Haematol 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.